Open AccessExpression of cyclooxygenase-2, vascular endothelial growth factor, and epidermal growth factor receptor in Chinese patients with esophageal squamous cell carcinoma
Author(s) -
Yong Cui,
Cheng Dong,
Bingquan Wu,
Xinchun Duan,
Guang Shi,
Ming Gong,
Tianyou Wang
Publication year - 2015
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.163838
Subject(s) - epidermal growth factor receptor , esophageal squamous cell carcinoma , vascular endothelial growth factor , cyclooxygenase , growth factor receptor inhibitor , vascular endothelial growth factor c , cancer research , basal cell , epidermal growth factor , vascular endothelial growth factor a , vegf receptors , medicine , carcinoma , receptor , oncology , biology , enzyme , biochemistry
Esophageal squamous cell carcinoma (ESCC) is a frequently occurring cancer with poor prognosis despite combined therapeutic strategies. The aim of the current study was to elucidate a further finding on the clinicopathologic significance of immunohistochemical expression of cyclooxygenase-2 (COX-2), vascular endothelial growth factor (VEGF), and epidermal growth factor receptor (EGFR) in Chinese patients with ESCC.